Sarah, a 45-year-old woman, presents with a tender lump in her left breast. An x-ray confirms a small lump, and a biopsy determines it is malignant stage III breast cancer without hormone receptors. Treatment options for Sarah's aggressive cancer include chemotherapy to target cancer cells, radiation therapy using high-energy sources to kill cells, and potentially a mastectomy given the stage and size of the tumor. MicroRNAs that inhibit protein production and contribute to breast cancer development and treatment may also impact Sarah's case.